1Ray,Kausik K,Cannon et al. Intensive statin therapy in acute coronary syndromes: Clinical benefits and vascular biology[J]. Current Opinion in Lipidology,2004,15 (6) : 637～ 643.
2ch(o)nbeck,Uwe,Libby et al. Inflammation,immunity,and HMG-CoA reductase inhibitors:Statins as antiinflammatory agents [J]. Circulation, 2004: 109 (21):Ⅱ -18～Ⅱ-26.
5Walter,Dirk H,Zeiher et al. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells [J]. Coronary Artery Disease, 2004, 15 (5): 235 ～242.
6Naghavi,Morteza,Libby. From vulnerable plaque to vulnerable patient :A call for new definitions and risk assessment strategies [J]. Circulation, 2003,108 (14):1664～1672.
1[1]Braunwald E, Califf RM, Cannon CP, et al. Redefining medical treatment in the management of unstable Angina[J]. Am J Med, 2000,108:41.
2[2]Yamashito K, Ouchi K, Shirai M, et al. Distribution of chlamydia pneumonia infection in the atherosclerotic carotic artery[J]. Stroke, 1998,29:773.
3[3]Mehta JL, Saldeen TG, Rand K. Interaction role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease[J]. J Am Coll Cardiol, 1998,31:1217.
4[4]Jerffery L, Anderson MD, Facc JF, et al. Evaluation of C-reactive protein, an inflammatory marker and infectious serology as risk factors for coronary disease and myocardial infaction[J]. J Am Coll Cardiol, 1998,32:35.
5[5]Tataru MC, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J, 2000,21:1000.
6[6]Oltrona L, Ardissino D,Merlini PA, et al. C-reactive protein elevation and early outcome in patients with unstable angina pectoris[J]. Am J Cardiol, 1997,80:1002.
7[1]Ross R. Atherosclerosis-An inflammatory disease. N Eng J Med, 1999, 340 (2): 115-126
8[2]Laman JD, De Smet BJ, Schoneveld A, Van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol Today, 1997, 18 (6): 272-277
9[3]Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implication for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA, 1997, 94 (5): 1 931-936
10[4]Rosenson RS,Tangney CC. Antiatherothrombotic properties of statins: implication for cardiovascular event reduction. JAMA, 1998, 279 (20): 1 643-650
